Fourth SARS-CoV-2 vaccination also protects cancer patients

by Johannes Angerer,Medical University of ViennaReceptor-Binding Domain and Angiotensin-Converting Enzyme 2 Interaction Inhibition in Patients With Hematologic Malignant Neoplasm With or Without

Updated on: December 20,2023

Fourth SARS-CoV-2 vaccination also protects cancer patients

by Johannes Angerer,Medical University of ViennaReceptor-Binding Domain and Angiotensin-Converting Enzyme 2 Interaction Inhibition in Patients With Hematologic Malignant Neoplasm With or Without

Updated on:December 20,2023

Anti-PF4 Immunothrombosis Absent Proximate Heparin or Adenovirus Vector Vaccine Exposure

February 2024Lara C. Pullen, PhDNew research reveals that patients with thrombocytopenia, thrombosis, and very high D-dimer levels could have platelet-activating vaccine-induced immune thrombocytopeni

Updated on: February 18,2024

Anti-PF4 Immunothrombosis Absent Proximate Heparin or Adenovirus Vector Vaccine Exposure

February 2024Lara C. Pullen, PhDNew research reveals that patients with thrombocytopenia, thrombosis, and very high D-dimer levels could have platelet-activating vaccine-induced immune thrombocytopeni

Updated on:February 18,2024

Research highlights breast cancer risk for female firefighters

bySilent Spring InstituteCredit: Pixabay/CC0 Public DomainIt's well documented that firefighters have significantly higher rates of cancer than the general population, and these elevated rat

Updated on: December 02,2024

Research highlights breast cancer risk for female firefighters

bySilent Spring InstituteCredit: Pixabay/CC0 Public DomainIt's well documented that firefighters have significantly higher rates of cancer than the general population, and these elevated rat

Updated on:December 02,2024

New form of immunotherapy under investigation for cancer that resists conventional T cell therapies

by Delthia Ricks , Medical XpressAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainMedical investigators are theorizing that a combination of t

Updated on: January 25,2024

New form of immunotherapy under investigation for cancer that resists conventional T cell therapies

by Delthia Ricks , Medical XpressAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainMedical investigators are theorizing that a combination of t

Updated on:January 25,2024

Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer

by Fred Hutchinson Cancer CenterCredit: CC0 Public DomainA blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detect

Updated on: March 20,2024

Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer

by Fred Hutchinson Cancer CenterCredit: CC0 Public DomainA blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detect

Updated on:March 20,2024

Gene loss enhances metastasis and cancer progression

by Melissa Rohman,Northwestern UniversityAn in vivo genome-wide CRISPR-Cas9 KO screen identifying CTC-promoting genetic factors. (A) Experimental design of the genome-wide CRISPR-Cas9 KO screen

Updated on: December 25,2023

Gene loss enhances metastasis and cancer progression

by Melissa Rohman,Northwestern UniversityAn in vivo genome-wide CRISPR-Cas9 KO screen identifying CTC-promoting genetic factors. (A) Experimental design of the genome-wide CRISPR-Cas9 KO screen

Updated on:December 25,2023

'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues

by Aslan Mansurov,The ConversationDendritic cells (green) produce cytokines like IL-12, which can train T cells (pink) to attack tumors. Credit:Victor Segura Ibarra and Rita Serda/National

Updated on: March 30,2024

'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues

by Aslan Mansurov,The ConversationDendritic cells (green) produce cytokines like IL-12, which can train T cells (pink) to attack tumors. Credit:Victor Segura Ibarra and Rita Serda/National

Updated on:March 30,2024

Harms reporting is inconsistent across organ cancer guidelines

byAmerican College of PhysiciansCredit: CC0 Public DomainA review of 33 organ-specific cancer screening guidelines has found that the reporting of harms related to screening tests and procedures

Updated on: December 22,2023

Harms reporting is inconsistent across organ cancer guidelines

byAmerican College of PhysiciansCredit: CC0 Public DomainA review of 33 organ-specific cancer screening guidelines has found that the reporting of harms related to screening tests and procedures

Updated on:December 22,2023

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on: January 04,2024

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on:January 04,2024

Study offers a potential strategy to improve T cell therapy in solid tumors

byPerelman School of Medicine at the University of PennsylvaniaRegnase-1 and Roquin-1 double knockout alters the activation profile of resting engineered T cells. (A) Healthy human donor T cells

Updated on: December 22,2023

Study offers a potential strategy to improve T cell therapy in solid tumors

byPerelman School of Medicine at the University of PennsylvaniaRegnase-1 and Roquin-1 double knockout alters the activation profile of resting engineered T cells. (A) Healthy human donor T cells

Updated on:December 22,2023

How the environment is silently shaping cancer risk: Data helps untangle links between pollution and cancer

by Niyati Jain,University of ChicagoDifferential expression of gene pathways in BCC (in blue) compared to healthy skin tissue (in red) by PTCH1 mutational status. BCC tissues with no non-synonym

Updated on: December 01,2024

How the environment is silently shaping cancer risk: Data helps untangle links between pollution and cancer

by Niyati Jain,University of ChicagoDifferential expression of gene pathways in BCC (in blue) compared to healthy skin tissue (in red) by PTCH1 mutational status. BCC tissues with no non-synonym

Updated on:December 01,2024

Transistors help identify cancer cell markers

by Tokyo Medical and Dental UniversityIon-sensitive field effect transistors detect breast cancer cells expressing EGFR when bound by an antibody linked to a chemical reporter. Credit: Department of B

Updated on: December 26,2023

Transistors help identify cancer cell markers

by Tokyo Medical and Dental UniversityIon-sensitive field effect transistors detect breast cancer cells expressing EGFR when bound by an antibody linked to a chemical reporter. Credit: Department of B

Updated on:December 26,2023